Core Peptides full review 2026 — testing, shipping, verdict
Core Peptides (USA) holds Editor's Choice for the second consecutive year on PeptideGuide's US leaderboard with a 9.2/10 composite score. This brand review covers the testing protocol, COA structure, US-domestic shipping reality, affiliate program economics, customer support, the peptide-only catalog rationale, and competitive positioning vs SwissChems, BioLongevity Labs, and the post-shutdown legacy of Amino Asylum and Peptide Sciences.
Founded 2019, Core Peptides operates a US-domestic facility with shipping out of a continental US warehouse. The 7-year operating history is mid-tier among credible US peptide vendors — younger than SwissChems (2018) but with no compliance incidents in operating history. The peptide-only catalog (no SARMs, no nootropics, no research-chemicals) is a deliberate compliance posture that limits regulatory blast radius if any single product line draws FDA attention.
Testing protocol: every batch ships with HPLC (purity), LC-MS (identity confirmation), and endotoxin testing. Reported purity is 99.1% on flagship products — credible for the price tier. Testing documentation is per-batch, accessible via order page within 24-48h of receipt. The protocol is one tier shallower than EU premium vendors (no CLND peptide content, no bioburden, no heavy metals as standard) but matches the US market median for credible vendors and exceeds the testing of mass-market alternatives.
Shipping: US-domestic via USPS or UPS depending on order weight, 2-3 business days coast-to-coast. Free shipping over $100. No international shipping at all — Core Peptides explicitly does not export. For US researchers this is an operational advantage: zero customs friction, predictable delivery, USD pricing without FX. For non-US researchers, Core Peptides is not an option; the equivalent in other regions is the regional Editor's Choice (Polar Peptides for CA, Pharma Lab Global for AU, Particle Peptides for EU).
Affiliate program: 10% commission per sale with a 30-day cookie window. Approval-based — applicants need a content track record. Net-30 payment via PayPal, wire, or cryptocurrency. The 10% rate is mid-tier — SwissChems offers 20% but with no cookie window. For long-cycle conversions, Core Peptides' 30-day cookie outperforms SwissChems' no-cookie model on educational content; for high-intent landing pages, SwissChems' commission rate wins.
Pricing tier: Core Peptides sits in the mid-tier — BPC-157 5mg ~$38 vs SwissChems ~$22 (lower) or premium boutique vendors at ~$60+. Pricing reflects domestic warehousing + tested COAs at moderate volume. For institutional researchers, the pricing premium over SwissChems is justified by the cleaner regulatory profile and 4.8/5 Trustpilot from 420+ verified reviews (vs SwissChems' lack of public review aggregation).
Customer support: English only. Email-based ticketing with typical 24-48h response. No live chat. Service quality is strong on order-status and shipping queries; technical questions (testing protocol detail, batch-specific COA queries) are answered but slower. The peptide-only catalog means support staff specialize — they don't have to context-switch between SARM regulatory questions and peptide testing questions.
Regulatory profile: research-use-only labeled across the catalog, no therapeutic claims. The peptide-only positioning matters in the post-Amino-Asylum US enforcement climate — FDA's June 2025 raid on Amino Asylum was triggered by therapeutic-claim marketing combined with research-chemicals catalog scope. Core Peptides has neither vector. DEA and state-level enforcement in California and Texas is not currently focused on peptide vendors with clean labeling, but the operational risk for vendors with broader catalogs is real.
Competitive positioning: vs SwissChems — Core Peptides has cleaner regulatory profile and verified review aggregation; SwissChems has lower prices and higher affiliate commission. Many US researchers run both as primary + secondary. vs BioLongevity Labs — Core Peptides has more established testing documentation and longer operating history; BioLongevity Labs has more competitive pricing on specific GLP-1 analogs. vs the post-shutdown legacy of Amino Asylum (FDA-raided June 2025) and Peptide Sciences (voluntary shutdown 2026-03-06) — Core Peptides absorbed customer migration from both during 2025-2026 and is the de facto market leader.
Verdict: Core Peptides is the Editor's Choice for US institutional and quality-conscious research peptide buyers. The combination of clean regulatory posture, peptide-only catalog, US-domestic 2-3 day shipping, and verified review aggregation outweighs the higher unit price vs SwissChems. For affiliate content, the 30-day cookie + 10% commission supports educational content economics. For non-US researchers, the US-domestic-only shipping rules out Core Peptides — see the regional Editor's Choice tables.
✓Pros
- HPLC + LC-MS + endotoxin testing — strong COA standard for the US tier
- US-domestic 2-3 day shipping — predictable, no customs
- 4.8/5 Trustpilot from 420+ verified reviews
- Peptide-only catalog — clean regulatory profile
- 10% affiliate program with 30-day cookie window
- Free shipping over $100
×Cons
- US-domestic only — no international shipping
- No SEPA or bank transfer payment
- Affiliate program requires approval
- Testing depth one tier below EU premium vendors
How does Core Peptides' testing compare to EU premium vendors?
Core Peptides ships HPLC + LC-MS + endotoxin per batch — strong for the US tier. EU premium vendors (Particle Peptides, PeptidesDirect) add CLND peptide content, bioburden, heavy metals, sterility — a deeper protocol. For US researchers without practical EU vendor access, Core Peptides is the right tier; for institutional buyers with global vendor access, the EU premium tier offers more depth.
Does Core Peptides ship internationally?
No. Core Peptides ships only to US addresses. For Canadian researchers, Polar Peptides is the equivalent regional pick. For Australia, Pharma Lab Global. For EU, Particle Peptides. The US-domestic-only posture is part of the clean regulatory profile — Core Peptides avoids customs risk on international shipments.
Why is the peptide-only catalog a regulatory advantage?
The June 2025 FDA raid on Amino Asylum was triggered by therapeutic-claim marketing combined with broad research-chemicals catalog scope (SARMs, nootropics, peptides). Vendors with broader catalogs draw broader regulatory attention. Core Peptides' peptide-only posture limits the regulatory blast radius — if FDA tightens enforcement on any specific product class, the catalog scope minimizes exposure.
Is Core Peptides' affiliate program worth it for content creators?
For educational content with long consideration cycles, the 30-day cookie + 10% commission supports the economics. For high-intent buy-now landing pages, SwissChems' 20% commission (no cookie) often wins. Many content creators run both — Core Peptides as the recommended pick on review/educational content, SwissChems as the alternative pick. Disclose all affiliate relationships under FTC Endorsement Guides (16 CFR Part 255).
What happened to Amino Asylum and Peptide Sciences?
Amino Asylum was FDA-raided June 2025 over therapeutic-claim marketing across SARMs + peptides catalog. Peptide Sciences voluntarily shut down 2026-03-06 (operator decision; no enforcement action). Customer migration from both to Core Peptides was the dominant pattern in the US market during 2025-2026. Do not attempt to order from legacy domains.
How does Core Peptides handle batch-specific COA requests?
Each order page links to the batch-specific COA within 24-48h of receipt. The COA includes HPLC chromatogram, LC-MS identity confirmation, and endotoxin result for that production batch. For institutional researchers requiring documentation chain-of-custody, support can provide per-batch documentation packets via email request — typical 1-2 business day turnaround.